Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overweight or Obesity; Type 2 Diabetes”

212 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 212 results

Post-approval studies (Phase 4)UnknownNCT05870462
What this trial is testing

Semaglutide and Vascular Regeneration

Who this might be right for
AtherosclerosisCardiovascular DiseasesDiabetes Mellitus, Type 2+1 more
Canadian Medical and Surgical Knowledge Translation Research Group 100
Post-approval studies (Phase 4)Active Not RecruitingNCT06860841
What this trial is testing

Effects of D-Chiro-Inositol Combined with Metformin on Insulin Resistance in People with Overweight or Obesity and T2DM

Who this might be right for
Type 2 DiabetesOverweight and Obese Adults
Campus Bio-Medico University 16
Testing effectiveness (Phase 2)Study completedNCT06131372
What this trial is testing

A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo

Who this might be right for
Chronic Kidney DiseaseType 2 DiabetesObesity
Novo Nordisk A/S 626
Not applicableEnded earlyNCT02443753
What this trial is testing

EndoBarrier® SANS™ in Over-weight or Obese Type 2 Diabetic Subjects

Who this might be right for
ObesityType 2 Diabetes
Morphic Medical Inc. 7
Not applicableStudy completedNCT00458029
What this trial is testing

Middle-School Based Primary Prevention Trial of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 4,603
Large-scale testing (Phase 3)Looking for participantsNCT07595549
What this trial is testing

Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Who this might be right for
ObesityOverweight and/or ObesityOverweight
Pfizer 954
Not applicableUnknownNCT01443143
What this trial is testing

Blood Glucose Stability and Variability on Two Diets

Who this might be right for
Type 2 DiabetesObesity
Nutrisystem, Inc. 15
Post-approval studies (Phase 4)Not Yet RecruitingNCT07555730
What this trial is testing

AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)

Who this might be right for
Overweight or Obesity; Type 2 DiabetesWeight Loss Maintenance
Huazhong University of Science and Technology 400
Not applicableStudy completedNCT04182646
What this trial is testing

Effect of Adjustable Intragastric Balloon in Obese Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-Alcoholic SteatohepatitisObesity+1 more
Asian Institute of Gastroenterology, India 36
Testing effectiveness (Phase 2)Looking for participantsNCT07783802
What this trial is testing

Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Who this might be right for
AtherosclerosisCardiovascular DiseaseObesity+3 more
Eli Lilly and Company 120
Not applicableStudy completedNCT01441323
What this trial is testing

Strength Training and Nutrition Development for African American Youth

Who this might be right for
ObesityType 2 DiabetesCardiovascular Risk+1 more
University of Southern California 62
Not applicableStudy completedNCT01231984
What this trial is testing

Comparison of Glycemic Control in Obese Diabetics Using Three Different Pen Needles

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Becton, Dickinson and Company 293
Not applicableNot Yet RecruitingNCT07809568
What this trial is testing

Real-World Outcomes of Tirzepatide in Pakistani Adults With Obesity, Prediabetes, and Type 2 Diabetes

Who this might be right for
Prediabetes or OverweightObesity Type 2 Diabetes MellitusObesity & Overweight
Universiti Sains Malaysia 330
Not applicableLooking for participantsNCT07376655
What this trial is testing

Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life

Who this might be right for
Diabetes Type 2Overweight or Obesity
Yale University 20
Early research (Phase 1)Study completedNCT06567041
What this trial is testing

A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Obesity
Novo Nordisk A/S 82
Large-scale testing (Phase 3)Study completedNCT05929066
What this trial is testing

Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

Who this might be right for
ObesityOverweightOsteoarthritis, Knee+1 more
Eli Lilly and Company 2,335
Post-approval studies (Phase 4)Enrolling By InvitationNCT06845345
What this trial is testing

Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)

Who this might be right for
Diabetes Mellitus, Type 2Liver FibrosisLiver Steatoses+9 more
Carmen Dietvorst 70
Not applicableNot Yet RecruitingNCT05857319
What this trial is testing

Study Consortium for Evaluation of RNPC Program in Obese and Overweight Patients (SCOOP-RNPC)

Who this might be right for
Overweight and ObesityCardiovascular DiseasesMetabolic Disease+4 more
Groupe Éthique et Santé 10,000
Not applicableStudy completedNCT05963594
What this trial is testing

To Evaluate the Post-Prandial Metabolic Effects of Oligomalt in Adults With T2D and in HAO

Who this might be right for
Dietary Supplement
Société des Produits Nestlé (SPN) 44
Testing effectiveness (Phase 2)Study completedNCT05936151
What this trial is testing

Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Who this might be right for
Overweight or ObesityCKDType 2 Diabetes
Eli Lilly and Company 146
Next Page